Qube Research & Technologies (QRT)’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-450	Closed	-$25.6K	–	3798
2025 Q2	$25.6K	Buy	+450	New	+$23.9K	﹤0.01%	3236
2024 Q3	–	Sell	-2,639	Closed	-$299K	–	3756
2024 Q2	$299K	Buy	+2,639	New	+$283K	﹤0.01%	2305
2024 Q1	–	Sell	-434	Closed	-$52.9K	–	4694
2023 Q4	$52.9K	Buy	434 +378	+675%	+$28.9K	﹤0.01%	3299
2023 Q3	$4.26K	Buy	56 +25	+81%	+$2.57K	﹤0.01%	3475
2023 Q2	$19.2K	Buy	+31	New	+$3.86K	﹤0.01%	2164
2022 Q4	–	Sell	-1,068	Closed	-$150K	–	2766
2022 Q3	$150K	Buy	+1,068	New	+$196K	﹤0.01%	1852
2021 Q2	–	Sell	-39	Closed	-$61K	–	2552
2021 Q1	$61K	Buy	+39	New	+$91.3K	﹤0.01%	1774
2020 Q4	–	Sell	-5	Closed	-$5K	–	2027
2020 Q3	$5K	Buy	+5	New	+$5.73K	﹤0.01%	1599

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LABU Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2025, closing a stake of 450 shares — an estimated $25.6K sold.

Qube Research & Technologies (QRT) first reported a position in LABU in Q3 2020 and held it in 8 quarters. The position peaked at $299K in Q2 2024. 39 funds tracked by Wall St. Rank hold LABU as of Q3 2025.

Qube Research & Technologies (QRT) reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 450 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2025, an estimated $25.6K.
Qube Research & Technologies (QRT) first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2020 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s Direxion Daily S&P Biotech Bull 3X ETF position peaked at $299K in Q2 2024.
39 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.